Source: Health Products Regulatory Authority (ZA) Revision Year: 2023 Publisher: Pharmacorp (Pty) Ltd, 29 Victoria Link, Route 21 Corporate Park, Irene, 0178, South Africa
PONAC FORTE is indicated for the treatment of post traumatic conditions such as pain, swelling and inflammation, for a maximum period of five (5) days. PONAC FORTE is also indicated as treatment of primary dysmenorrhoea, subject to a maximum daily dose of 500 mg three (3) times a day for a maximum of three (3) days.
Use the lowest effective dose for the shortest possible duration of treatment. PONAC FORTE must be taken with meals.
Relief of mild to moderate pain: 500 mg three (3) times a day.
Acute pain: an initial dosage of 500 mg, thereafter 250 mg every six (6) hours for a maximum treatment period of five (5) days.
Primary dysmenorrhoea: a maximum daily dose of 500 mg three (3) times a day and a maximum treatment period of three (3) days.
Oral use only.
Mefenamic acid such as in PONAC FORTE has a marked tendency to induce tonic-clonic (grand mal) convulsions in overdosage. Dyskinesia, acute renal failure and coma have been reported. Overdose has led to fatalities.
Prolonged use at higher than recommended doses may result in severe hypokalaemia and renal tubular acidosis. Symptoms may include reduced level of consciousness and generalised weakness (see section 4.4 and section 4.8).
Treatment is symptomatic and supportive. Vital functions should be monitored and supported. Haemodialysis is of little value since mefenamic acid and its metabolites are firmly bound to plasma proteins.
24 months.
Store in a cool dry place at or below 25°C.
Keep the blisters in the carton until required for use.
Keep in the original container.
Protect from light.
PONAC FORTE tablets are either packed in a PP container with LDPE closure cap with foam insert and silica gel sachet or in blister packs (foil and blister PVC).
Pack size: 10’s.
Not all packs may be marketed.
No special precautions are required.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.